Skip to main content
Article thumbnail
Location of Repository

Rivastigmine in Chinese patients with subcortical vascular dementia

By Vincent Mok, Adrian Wong, Simon Ho, Thomas Leung, Wynnie WM Lam and Ka Sing Wong
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2656338
Provided by: PubMed Central

Suggested articles

Citations

  1. (2003). A comparison of the cognitive benefi ts of donepezil in patients with cortical and subcortical vascular dementia.
  2. (2000). Behavioral differences between white matter lacunar dementia and Alzheimer’s disease: a comparison on the neuropsychiatric inventory. Dement Geriatr Cogn Disord,
  3. (2005). Dementia subtypes in China: prevalence in
  4. (2003). Donepezil in vascular dementia: a randomized, placebo-controlled study.
  5. (1999). Effi cacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial.
  6. (2003). Effi cacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
  7. (2002). Effi cacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial.
  8. (2004). Frequency and determinants of poststroke dementia in Chinese. Stroke,
  9. (2006). Galantamine for vascular cognitive impairment. Cochrane Database Syst Rev,
  10. (2005). Global prevalence of dementia: a Delphi consensus study.
  11. (2001). Increased prevalence of vascular dementia in Japan: a community-based epidemiological study.
  12. (1994). Reliability and validity of the Cantonese version of Mini-mental state examination – a preliminary study. Hong Kong Coll Psychiatry,
  13. (2000). Research criteria for subcortical vascular dementia in clinical trials.
  14. (2003). Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.
  15. (2002). Rivastigmine in subcortical vascular dementia: an open 22-month study.
  16. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules.
  17. (2000). The FAB: a Frontal Assessment Battery at bedside.
  18. (1999). The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease.
  19. (2002). The validation of the Hong Kong Chinese Version of the Lawton Instrumental Activities of Daily Living Scale for Institutionalized Elderly Persons. Occupation, Participation and Health,
  20. (2004). The validity and reliability of chinese frontal assessment battery in evaluating executive dysfunction among Chinese patients with small subcortical infarct. Alzheimer Dis Assoc Disord,
  21. (2005). Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings. Curr Med Res Opin,
  22. (2001). Validation study of the Chinese version of the neuropsychiatric inventory (CNPI).
  23. (2004). Zhiling decoction for vascular dementia. Cochrane Database Syst Rev,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.